Results 221 to 230 of about 183,492 (354)

Exploration of key markers driving ferroptosis in the progression of non-alcoholic fatty liver disease. [PDF]

PLoS One
Zhang J, Li W, Qiu X, Wang Y, Zeng Y.
europepmc   +1 more source

Ionic–Bionic Interfaces: Advancing Iontronic Strategies for Bioelectronic Sensing and Therapy

Advanced Science, EarlyView.
Ionic–bionic interfaces for bioelectronics leverage ions as multifunctional mediators that combine mechanical compliance, ionic and electronic functionalities, and therapeutic effects. These systems offer real‐time biosignal transduction, effective wound dressing, responsive drug delivery, and seamless interaction between soft tissues and electronic ...
Yun Goo Ro, Yoojin Chang, Jeeyoon Kim, Seungjae Lee, Sangyun Na, Cheolhong Park, Hyunhyub Ko   +6 more
wiley   +1 more source

Cholecystectomy and non-alcoholic fatty liver disease: Exploring the hidden connection and implications. [PDF]

World J Gastrointest Surg
Liu XY, Ma J, Jiao Y.
europepmc   +1 more source

Nanomedicines Against Mitochondrial Dysfunction‐Induced Metabolic Diseases

Advanced Science, EarlyView.
Mitochondrial dysfunction is central to metabolic diseases. Nanomedicine offers transformative approaches for restoring function via targeted delivery, responsive release, and multimodal therapy. This review outlines the pathological basis, nanocarrier design, organelle‐specific targeting, recent advances, and future clinical translation challenges ...
Ke Xu, Leyi Wang, Tao Lv, Chen Jin, Qiong Wu, Yongjie Zhou, Gang Xu, Zhenyu Duan, Kui Luo, Jiayin Yang   +9 more
wiley   +1 more source

Comparative efficacy of multiple drugs for non-alcoholic fatty liver disease: a Bayesian network meta-analysis. [PDF]

Eur J Med Res
Xiao Z, Li X, Gong J, Zhou F.
europepmc   +1 more source

Non-alcoholic fatty liver disease and insulin resistance are associated with increased cardiac oxidative stress in mice [PDF]

, 2013
Tomáš Jeleník, U Floegel, Esther Phielix, K Kaul, P. Nowotny, Hans-Joachim Partke, Jürgen Schrader, Michael Roden, Julia Szendroedi   +8 more
openalex   +1 more source

Fluorinated Carnitine Derivatives as Tools to Visualise Carnitine Transport and Metabolism

Advanced Science, EarlyView.
Fluorinated carnitines, fluoromethyl carnitine (FMC) and [18F]fluoromethyl carnitine ([18F]FMC), are synthesised and established as powerful probes to interrogate carnitine biology. The multimodal detection facilitated by fluorine labelling, including 19F NMR, mass spectrometry, and positron emission tomography imaging, allowed for visualisation of ...
Richard S. Edwards, Ella‐May Hards, Sofia N. dos Santos, Hannah E. Greenwood, Madeleine E. George, Andrea Emanuelli, Muhammet Tanc, Thomas R. Eykyn, Timothy H. Witney   +8 more
wiley   +1 more source

Mitochondrial transplantation and platelet rich plasma for the treatment of non-alcoholic fatty liver disease. [PDF]

World J Hepatol
Vargas-Vargas MA, González-Montoya M, Torres-Isidro O, Ortiz-Avila O, Calderón-Cortés E, Cortés-Rojo C.   +5 more
europepmc   +1 more source

Integrin β3 Orchestrates Hepatic Steatosis via a Novel CD36‐Dependent Lipid Uptake Complex

Advanced Science, EarlyView.
In MASH, ITGB3 recruits LYN and drives its ubiquitin‐proteasomal degradation via phosphorylation. This relieves DHHC5 inhibition, enabling ITGB3/DHHC5/CD36 complex assembly to enhance CD36 palmitoylation and fatty acid uptake, thereby exacerbating disease. Targeting ITGB3 blocks this pathogenic axis and ameliorates MASH.
Ying Zhang, Lei Dai, Zhongquan Cui, Ye Zhou, Wenyuan Dong, Hongcheng Jiang, Mengwen Wang, Xiaodan Zhong, Wei Dong, Zhang Yue, Thati Madhusudhan, Hongjie Wang, Xiong Zhong Ruan, Hesong Zeng   +13 more
wiley   +1 more source

Thyroid dysfunction in non-alcoholic fatty liver disease: A case-control study. [PDF]

Bioinformation
Malkan H, Patel B, G Solu M, D Patel T, Mubrakhusen Bhaniya MK.   +4 more
europepmc   +1 more source